Benoit Bardèche-Trystram

Benoit Bardèche-Trystram

Auto-generated profile, based on publicly available information

Benoit Bardèche-Trystram

Bioscar UMR Inserm 1132 and Université de Paris, F-75010 Paris, France

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
26 August 2022 in Science Advances
Verified
Journal Article
Open access
YJYohan Jouan
Yohan Jouan
ZBZohra Bouchemla
Zohra Bouchemla
BBBenoit Bardèche-Trystram
Benoit Bardèche-Trystram
JSJoanna Sana
Joanna Sana
CACaroline Andrique
Caroline Andrique
EHEric Hay
Eric Hay
Articular cartilage has low regenerative capacity despite permanent stress. Irreversible cartilage lesions characterize osteoarthritis (OA); this is not followed by tissue repair. Lin28a, an RNA binding protein, is detected in damaged cartilage in humans and mice. We investigated the role of LIN28a in cartilage physiology and in osteoarthritis. Lin28a-inducible conditional cartilage deletion up-regulated Mmp13 in intact mice and exacerbated the cartilage destruction in OA mice. Lin28a-specific cartilage overexpression protected mice against cartilage breakdown, stimulated chondrocyte proliferation and the expression of Prg4 and Sox9, and down-regulated Mmp13 . Lin28a overexpression inhibited Let-7b and Let-7c miRNA levels while RNA-sequencing analysis revealed five genes of transcriptional factors regulated by Let-7. Moreover, Lin28a overexpression up-regulated HMGA2 and activated SOX9 transcription, a factor required for chondrocyte reprogramming. HMGA2 siRNA knockdown inhibited the cartilage protective effect of Lin28a overexpression. This study provides insights into a new pathway including the Lin28a-Let7 axis, thus promoting chondrocyte anabolism in injured cartilage in mice.